Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-031086
Filing Date
2012-05-18
Accepted
2012-05-18 15:39:43
Documents
1
Period of Report
2012-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd345958.html 4  
1 FORM 4 rrd345958.xml 4 2969
  Complete submission text file 0001181431-12-031086.txt   4384
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 425 JANISH DR SANDPOINT ID 83864
Business Address
CZIRR JAMES C (Reporting) CIK: 0001260641 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 12855366